r information identifying
legislative or regulatory, economic, climatic, currency, technological,
competitive and other important factors that could cause actual results to
differ materially from those anticipated in the forward looking statements,
see CryoCath's annual report available at
http://www.sedar.com under the heading
Risks and Uncertainties in the Management's Discussion and Analysis
section. The financial results referred to in the press release and
accompanying statements are unaudited and may differ from the final audited
numbers.
Balance Sheets (unaudited)
As at September 30 2007 2006
$ $
ASSETS
Current assets
Cash and cash equivalents 9,139,844 9,178,123
Cash subject to restrictions 612,500 -
Short-term investments held-to-maturity 14,894,481 5,616,907
Accounts receivable 7,027,518 8,119,660
Investment tax credits receivable 296,840 502,033
Inventories 7,701,067 7,105,974
Prepaid expenses 1,143,381 1,044,039
-------------------------------------------------------------------------
Total current assets 40,815,631 31,566,736
Cash subject to restrictions 700,000 -
Balance of sale receivable 1,563,195 -
Net investments in leases - 5,967
Deferred financing charges - 2,636,636
Consoles at customers' premises 1,475,631 1,858,465
Property, plant, and equipment 2
'/>"/>
SOURCE CryoCath Technologies Inc. Copyright©2007 PR Newswire. All rights reserved | |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 Related medicine news :1.
CryoCath files patent infringement lawsuit2.
CryoCath to present at CIBC Healthcare Conference3.
CryoCath to present at Piper Jaffray and BMO Healthcare conferences4.
HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness5.
CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael6.
UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West7.
HEI, Inc. Announces Sale of RFID Division Assets8.
Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)9.
Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference10.
Z Trim Announces Revocation of Gregory Halpern Severence Agreement11.
Brooke Franchise Corporation Announces Selected July Results